(Press-News.org) PITTSBURGH, July 6, 2015 - University of Pittsburgh Cancer Institute (UPCI) scientists recently led a panel of experts in revising national guidelines for thyroid cancer testing to reflect newly available tests that better incorporate personalized medicine into diagnosing the condition.
Their clinical explanation for when to use and how to interpret thyroid cancer tests is published in the July issue of the scientific journal Thyroid. The American Thyroid Association is revising its 2015 Guidelines for Thyroid Nodule and Thyroid Cancer Management to direct doctors to the scientific publication.
"Minimally invasive molecular testing for thyroid cancer has improved by leaps and bounds in the last several years," said co-author Robert L. Ferris, M.D., Ph.D., professor and chief of the Division of Head and Neck Surgery in Pitt's School of Medicine. "But different tests perform differently and, therefore, need to be interpreted carefully to make the best decisions regarding extent of surgery for patients with thyroid nodules. Our goal with this analysis is to give clinicians a clear understanding of what each type of test can tell them and when to use them to determine the best course of treatment."
Cancer in the thyroid, which is located just below the "Adam's apple" area of the neck, is the fifth most common cancer diagnosed in women. Thyroid cancer is one of the few cancers that continues to increase in incidence, although the five-year survival rate is 97 percent.
UPCI, partner with UPMC CancerCenter, has been a national leader in developing personalized genetic tests for thyroid cancer that have spared patients repeat or unnecessary surgeries. A low-cost test called ThyroSeq, developed by a team led by Yuri Nikiforov, M.D., Ph.D., director of Pitt's Division of Molecular and Genomic Pathology, allows pathologists to simultaneously test for multiple genetic markers of thyroid cancer using just a few cells collected from the nodule.
This allows doctors to "rule-in" a specific cancer diagnosis with a high degree of certainty, without a biopsy to remove a large portion of the thyroid, which would then have to be followed with a second surgery if cancer is detected to remove the entire gland. As Dr. Nikiforov's group added more genetic sequences to the ThyroSeq test to create a larger and more sensitive version of the test, it is now also performing as a "rule-out" test that can tell doctors with a high degree of certainty that a patient does not have cancer.
Other available tests use different technology to serve as accurate "rule-out" tools, but do not have the high sensitivity needed to also reliably "rule-in" cancer. And, in some cases, the accuracy of the "rule out" tests depends on the prevalence of cancer in the patients seen by each individual cancer institute. This is critical because clinicians must know this rate at their institution to correctly calculate the accuracy of "rule-out" test results for each patient.
In addition to Dr. Ferris and co-author Sally E. Carty, M.D., who is professor and chief of the Division of Endocrine Surgery in Pitt's School of Medicine and co-director of the UPMC/UPCI Multidisciplinary Thyroid Center, the panel reviewing the tests was a multidisciplinary group from a dozen institutions in the U.S. and Canada.
"This was a very innovative and collegial initiative," said Dr. Carty. "Through an objective review of the existing tests and the scientific literature characterizing their performance, we are seeking to help clinicians make the best decisions for their patients."
Dr. Ferris agrees, noting that "this is an exciting time in personalized medicine, and these tests give us the ability to not only better diagnose and treat thyroid cancer, but also significantly reduce surgeries for people who don't have cancer."
INFORMATION:
Additional authors on this publication are Zubair Baloch, M.D., Ph.D., University of Pennsylvania Medical Center; Victor Bernet, M.D., Mayo Clinic; Amy Chen, M.D., Emory University; Thomas J. Fahey III, M.D., New York Presbyterian Hospital; Ian Ganly, M.D., Ph.D., and Ashok Shaha, M.D., both of Memorial Sloan-Kettering Cancer Center; Steven P. Hodak, M.D., and Kepal N. Patel, M.D., both of New York University Medical Center; Electron Kebebew, M.D., National Cancer Institute; David L. Steward, M.D., University of Cincinnati Medical Center; Ralph P. Tufano, M.D., Johns Hopkins University; and Sam M. Wiseman, M.D., St. Paul's Hospital & University of British Columbia.
About UPCI
As the only NCI-designated comprehensive cancer center in western Pennsylvania, UPCI is a recognized leader in providing innovative cancer prevention, detection, diagnosis, and treatment; bio-medical research; compassionate patient care and support; and community-based outreach services. Investigators at UPCI, a partner with UPMC CancerCenter, are world-renowned for their work in clinical and basic cancer research.
http://www.upmc.com/media
Alexandria, VA - With the Internet, science and a little imagination, scientists are able to bring remote worlds to life. Dinologue.com brings the Mesozoic to life, and EARTH Magazine reviews it in the July 2015 issue.
The website was created through a partnership between Parallax Film Productions and popular science writer, and amateur paleontologist, Brian Switek. The Dinologue portal is filled with captivating articles and adventurous videos to help bring science and paleontology to the masses. Get the geoscientist's perspective of Dinologue in EARTH Magazine: http://bit.ly/1JJDy7r.
The ...
Researchers have provided a new roadmap for tackling future agricultural production issues by using solutions that involve crassulacean acid metabolism (CAM), a specialized type of photosynthesis that enhances the efficiency by which plants use water.
Plants that use CAM, which include cacti and agave, are typically found in dry environments. Increasing agricultural production to accommodate society's growing population might be achieved by developing CAM crops as new sources for food, feed, fiber, and bioenergy or by engineering non-CAM crops to use CAM strategies to ...
Putnam Valley, N.Y. (July 6, 2015) - Peripheral nerve injuries often are caused by trauma or surgical complications and can result in considerable disabilities. Regeneration of peripheral nerves can be accomplished effectively using autologous (self-donated) nerve grafts, but that procedure may sacrifice a functional nerve and cause loss of sensation in another part of the patient's body.
Searching for an alternative to autologous nerve grafts (autografts), researchers in Japan transplanted mobilized dental pulp stem cells (MDPSCs) into laboratory rats with sciatic nerve ...
By studying climate data in the British-Irish Isles over a 142-year period, researchers have confirmed the important role of cyclones. Seasonal precipitation totals were strongly related to cyclone frequency, especially during summer.
The researchers found that relative to the 1961-1990 period, summers have become much wetter and more cyclonic. The move towards wetter summers in recent years is more of a re-establishment of conditions typical of the earlier half of the 20th Century rather than being unusual in the long term.
Recent years have seen three of the stormiest ...
For the first time, researchers have used a simplified technique derived from a defense mechanism evolved by bacteria and other single-celled organisms to successfully insert a large DNA sequence into a predetermined genomic site in mammalian cells.
The methods used may help investigators genetically engineer cells to produce high levels of certain proteins--for example by placing the DNA sequence of a particular protein at the site of a highly active gene.
"The CRISPR-Cas system has been previously used to insert a foreign DNA sequence into a targeted genomic site ...
Since Ebola was first described in 1976, there have been several outbreaks, but all have been self-limiting. In a new Journal of Internal Medicine review, Dr. Ali Mirazimi of the Karolinska Institutet considers why the latest outbreak occurred and discusses the factors that contributed to making it the largest, most sustained, and most widespread outbreak of Ebola. He also notes that several potential treatments are now undergoing clinical trials and have shown initial promising results.
"Emerging and re-emerging infectious diseases will continue to challenge both human ...
Researchers have developed a non-invasive technique that allows clinicians to accurately detect various forms of skin cancer.
The current clinical "gold standard" non-invasive technique, called dermoscopy, is a highly subjective method. But by using what's called Raman spectroscopy, investigators found that malignant melanoma could be detected with an accuracy of 91% and non-melanoma skin cancers could be detected with accuracy between 73% and 85%.
"The non-invasive and label-free nature of Raman spectroscopy enables the application in various medical fields. The method ...
Differences in the number of oil-secreting glands in the skin may help explain why wrinkles are shallower in the forehead than in the outer eye area, suggests new research conducted on cadavers.
Investigators suspect that the presence of oil-secreting glands and a thinner inner layer of skin, or dermis, may let the skin deform more easily and might be a cause for the development of wrinkles. The findings are published in Clinical Anatomy.
INFORMATION: ...
Long QT syndrome (LQTS), a rare hereditary heart condition, can lead to life-threatening arrhythmias, or fast heartbeat irregularities. New research indicates that children with LQTS who take medications for attention deficit/hyperactivity disorder (ADHD) are at increased risk of experiencing heart-related problems--especially syncope, or the loss of consciousness.
"In light of these findings, special attention is needed when prescribing ADHD medications for LQTS patients, starting with the lowest effective dose and planning close follow-up," said Dr. Valentina Kutyifa, ...
WASHINGTON (July 6, 2015) - The prevalence of cardiovascular risk factors like hypertension, high cholesterol, and diabetes have been decreasing in the United States and Europe, however they appear to be on the rise in Asia, particularly Japan, according to a guest editor page published today in the Journal of the American College of Cardiology.
Using data from epidemiological studies and examining a health program launched by the Japanese government, guest editor Masafumi Kitakaze, M.D., Ph.D., found many risk factors in the Japanese population remain unchanged or even ...
